SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Memecoin on Cronos launched by the Cro Crow community

crow with knife

The crypto CAW is trending due to community enthusiasm around the "crow with knife" meme and its potential during this bull run. The community is focused on its multichain expansion and strong community, using "caw caw" as a rallying cry. Some users highlight its deflationary mechanisms and are encouraging others to add it to their watchlists.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is trending amid community debate about its technology and future prospects, with some users expressing skepticism about eVTOL capabilities and range limitations. Bullish investors are pointing to upcoming events like the California International Air Show and potential military contracts as catalysts for growth. A possible collaboration with Tesla has also surfaced as a point of discussion among investors.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network is trending as the community discusses potential catalysts including upcoming news, partnerships, and the possibility of a major exchange listing. Bullish sentiment is fueled by comparisons to early XRP and anticipation of the Zebec Super App launch. Many believe ZBCN is positioned for significant growth and real-world adoption within the evolving financial landscape.

Reactive Network is the first parallelized interoperability execution layer, utilising a new form of smart contract we call reactive smart contracts.   Reactive smart contracts are able to react to on-chain events autonomously and execute their own user defined logic to initiate new transactions. This allows a virtually limitless number of use cases to achieve fully decentralized on-chain automation.

Reactive Network

Reactive Network ($REACT) is trending amid community excitement around its cross-chain automation capabilities and the upcoming sunsetting of $PRQ, which some believe has been suppressing its price. The community is also anticipating new exchange listings and marketing campaigns, while highlighting its strong technology and staking rewards. Discussions include potential price targets and the belief that $REACT is an undervalued gem with significant long-term potential.

UTZ Brands, Inc. manufactures, markets, and distributes branded snacking products. It offers a broad range of salty snacks, including potato chips, pretzels, cheese, veggie, other snacks and pork skins. The firm’s brands include Utz, Zapp’s, Golden Flake, Good Health, Boulder Canyon and Hawaiian. The company was founded in 1921 and is headquartered in Hanover, PA.

Utz Brands Inc - Ordinary Shares - Class A

Utz Brands is trending as the community discusses its recent earnings report, which beat expectations and prompted raised guidance. Community members are debating the impact of insider selling and a Goldman Sachs downgrade on the stock's price action, while others express confidence in the company's long-term potential and recession-resistant snack products.

Roundhill ETF Trust - Roundhill PLTR WeeklyPay ETF

PLTW is trending due to discussions surrounding its weekly distribution payouts and overall performance. Community members are comparing it to similar income-generating ETFs, highlighting both its price appreciation and consistent dividend payments. Some are speculating about its long-term potential as a steady income stream, while others discuss strategies for reinvesting dividends.

Investment Managers Series Trust II - Tradr 2X Long UPST Daily ETF

Tradr 2X Long UPST Daily ETF

Traders are actively discussing $UPSX, a 2x leveraged ETF for Upstart, with many highlighting it as a way to amplify potential gains from $UPST, especially amid anticipation of future rate cuts. The community is weighing the risks and rewards of using the ETF, with some expressing concerns about its correlation to the underlying stock and others seeing it as a potential high-reward play. Overall sentiment leans bullish, with some expecting a significant move if $UPST rebounds.

The Hershey Co. engages in the manufacture and marketing of chocolate, sweets, mints and confectionery products. The firm operates through the following segments: North America Confectionery, North America Salty Snacks and International. The North America Confectionery segment is responsible for the traditional chocolate and non-chocolate confectionery market position of the company, as well as its grocery and snacks market positions, in the United States and Canada. The North America Salty Snacks segment is responsible for the salty snack products in the United States. The International segment includes the combination of all other operating segments, including those geographic regions where the company operates outside of North America. Its brands include Hershey's, Reese's, and Kisses. The company was founded by Milton S. Hershey in 1894 and is headquartered in Hershey, PA.

Hershey Company

HSY is trending amid reports of a potential takeover by Mondelez, driving speculation and a notable price surge. While some traders are betting on a continued rise, others anticipate a pullback if the deal doesn't materialize, given concerns about high cocoa prices and potential market overvaluation.

Morgan Stanley operates as a global financial services company. The firm provides investment banking products and services to its clients and customers including corporations, governments, financial institutions, and individuals. It operates through the following segments: Institutional Securities, Wealth Management, and Investment Management. The Institutional Services segment provides financial advisory, capital-raising services, and related financing services on behalf of institutional investors. The Wealth Management segment offers brokerage and investment advisory services covering various types of investments, including equities, options, futures, foreign currencies, precious metals, fixed-income securities, mutual funds, structured products, alternative investments, unit investment trusts, managed futures, separately managed accounts, and mutual fund asset allocation programs. The Investment Management segment provides equity, fixed income, alternative investments, real estate, and merchant banking strategies. The company was founded by Harold Stanley and Henry S. Morgan in 1924 and is headquartered in New York, NY.

Morgan Stanley

Morgan Stanley ($MS) is trending due to a mix of factors, including unusual options activity and analyst ratings adjustments. Community discussions include call options activity, potential share buybacks, and its performance relative to peers in the financial sector. Some traders are noting technical indicators and potential entry points, while others discuss the broader market context.

ZIM Integrated Shipping Services Ltd. engages in the provision of shipping and logistics services. It offers shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. The company was founded on June 7, 1945 and is headquartered in Haifa, Israel.

Zim Integrated Shipping Services Ltd

ZIM is trending amid speculation of a potential buyout led by the CEO, which has driven a surge in stock price, although some believe the rumored offer undervalues the company. Community discussions revolve around the likelihood of the deal, potential counteroffers, and the stock's intrinsic value, while also considering freight rates and macro factors. Recent options activity shows balanced sentiment with both call and put buying.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Indian equity markets snapped their eight-day losing streak, with the Nifty index reclaiming 24,800, driven by a 700-point rally in Nifty Bank. This came after the Reserve Bank of India held steady on repo rates and revised inflation forecasts lower. The central bank also announced a slew of reforms for the banking space, including increased loan limits.On Wednesday, the Sensex closed 715 points higher at 80,983, while the&nbsp;<a href="https://stocktwits.com/symbol/NIFTY50.NSE">Nifty 50</a> ended up 225 points at 24,836. Broader markets mirrored the optimism, with the Nifty Midcap index rising 0.8% and the Smallcap index gaining 1.1%.However, the retail investor sentiment surrounding the Nifty 50 remained ‘bearish’ by market close on Stocktwits.<figure class="image"><img style="aspect-ratio:813/102;" src="https://news.stocktwits-cdn.com/Screenshot_2025_10_01_155746_png_5955436f5e.webp" alt="Screenshot 2025-10-01 155746.png" width="813" height="102"><figcaption>Nifty sentiment and message volume on Oct 1 as of 3:50 pm IST. | source: Stocktwits</figcaption></figure>Stock MovesSectorally, barring PSU banks, all indices ended in the green. Media (+4%), pharmaceuticals (+1.2%), and real estate (+1%) saw strong buying. A notable mover in the media space was Sun TV, which closed with 12% gains.Kotak Mahindra Bank, Axis Bank, ICICI Bank, and HDFC Bank were among the top Nifty gainers, driven by the RBI’s reforms push.&nbsp;<a href="https://stocktwits.com/symbol/TATAMOTORS.NSE">Tata Motors</a> ended over 5% higher after its <a href="https://stocktwits.com/news-articles/markets/equity/tata-motors-demerger-takes-effect-retail-investors-to-benefit-says-analyst/chCor1mR39A">demerger</a> came into effect; the record date has been set at October 14.<a href="https://stocktwits.com/symbol/PFIZER.NSE">Pfizer India</a> rose 3% after US President Donald Trump announced a deal with the American parent company to provide key prescription medications at steeply discounted prices through a new government-run online platform. The rest of the pharmaceutical space also saw a relief rally, with Sun Pharma and Lupin gaining 3%.&nbsp;Shriram Finance gained 5% after the company shot down reports that Japan’s Mitsubishi UFJ Financial Group (MUFG) was in talks to buy a 20% stake worth ₹23,200 crore.Stock Calls<a href="https://stocktwits.com/equitycharcha">Ashok Kumar Aggarwal of Equity Charcha</a> is bullish on TVS Supply Chain Solutions. It recently inaugurated a new facility in Iowa (USA) to support local manufacturing. On its technical charts, he noted that its Relative Strength Index (RSI) was ranging between 37 and 45 on its daily, weekly, and monthly time frame charts.&nbsp;He shared a short-to-medium term trade call on TVS Supply with an accumulation zone between ₹124-₹126 with a stop loss at ₹118 on a closing basis. The short-term target is set at ₹142, and a medium-term target price is ₹161.<stembedurl>https://stocktwits.com/equitycharcha/message/630578691</stembedurl><a href="https://stocktwits.com/Ca_mayankchandel">Mayank Singh Chandel</a> shared a swing trade call on&nbsp;<a href="https://stocktwits.com/symbol/HINDZINC.NSE">Hindustan Zinc</a>. He noted that the stock was consolidating near the gap resistance at ₹483.05, with rising volumes indicating strong upside interest. Chandel recommended a buy on a close above ₹483.05, with a stop loss at ₹463 and a target price of ₹535.<stembedurl>https://stocktwits.com/Ca_mayankchandel/message/630585738</stembedurl>Markets: What Next?<a href="https://stocktwits.com/WealthFino">Krishna Pathak&nbsp;</a>highlighted Nifty support near the 24,540–24,600 zone, with immediate resistance around the 24,800–24,900 levels. He added that the index was trading above the 9-day Exponential Moving Average (EMA), which indicates a short-term bullish momentum. If it breaks out above 24,800, it could open the path towards 24,900–25,100. But sustained weakness below 24,600 can extend declines towards 24,540.<stembedurl>https://stocktwits.com/WealthFino/message/630580092</stembedurl>Globally, European markets traded higher, while US stock futures indicate a weak start on Wall Street after a deadlock over healthcare and government spending led to the US government shutdown for a first time in nearly seven years.For updates and corrections, email newsroom[at]stocktwits[dot]com.&nbsp;

(Photo by Indranil Aditya/NurPhoto via Getty Images)

Banking Rally Lifts Indian Markets: RBI Policy Boosts Nifty To 24,800, Sensex Ends Near 81,000

Benchmarks staged a strong comeback on RBI’s supportive policy measures, though retail sentiment on Nifty 50 remained ‘bearish’ on Stocktwits.

Equity

Shares of Pfizer, the Indian arm of U.S.-based Pfizer Inc., rose more than 2% on Wednesday after President Donald Trump announced a deal with the drugmaker to provide key prescription medications at steeply discounted prices through a new government-run online platform, ‘TrumpRX.’Deal AnnouncementSpeaking at the White House, Trump said Pfizer agreed to supply several of its most widely used drugs at “heavily discounted prices of anywhere between 50% and even 100%,” allowing patients to pay cash directly on the new TrumpRX website.&nbsp;He added that all new Pfizer drugs introduced in the U.S. will be sold at “most favored patient costs,” ensuring prices are comparable to the lowest charged internationally.Pfizer CEO Albert Bourla said the company’s deal with the Trump administration satisfies all of the President’s requirements.&nbsp;He added that Pfizer has secured a three-year grace period from proposed tariffs on pharmaceutical imports, while also cutting prices on certain drugs. “The President is absolutely right—tariffs are the most powerful tool to motivate behavior, and they clearly motivated ours,” Bourla said.Trump also warned that companies refusing to lower prices could face additional tariffs of 5% to 8%, as his administration continues to pressure drugmakers to expand U.S.-based production before Oct. 1, 2025.Analyst ViewSEBI-registered analyst Sunil Kotak said that Pfizer’s daily chart shows a sideways trend, with the 50-day simple moving average (SMA) around ₹5,200 and a strong supply zone between ₹5,200–₹5,300.&nbsp;<stembedurl>https://stocktwits.com/Technofunda24/message/630578299</stembedurl>He noted that the stock would need to close above ₹5,300 for a fresh up-move, while the relative strength index (RSI) stands at 52, indicating consolidation for now.What Is The Retail Mood?On Stocktwits, retail sentiment for Pfizer was ‘bullish’ amid ‘high’ message volume.<a href="https://stocktwits.com/symbol/PFIZER.NSE">Pfizer’s stock</a> has declined 2.8% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, Pfizer’s logo is on a smartphone with an economic stock exchange index graph in the background. (Photo Illustration by Budrul Chukrut/SOPA Images/LightRocket via Getty Images)

Pfizer India Rises On Trump’s Drug Discount Deal — SEBI Analyst Eyes Breakout Above ₹5,300

Pfizer shares rose after the U.S. drugmaker struck a deal with the Trump administration to sell key medicines at steep discounts through a new federal website.

Indian equity markets have opened on a positive note as investors await the rate decision from India’s central bank. The street is expecting the Reserve Bank of India (RBI) to maintain a status quo with a dovish tone, but some expect a 25 bps rate cut.At 09:40 a.m. IST, the&nbsp;<a href="https://stocktwits.com/symbol/NIFTY50.NSE">Nifty 50</a> traded 59 points higher at 24,670, while the Sensex was up 182 points at 80,450. Broader markets were mixed, with the Nifty Midcap index rising 0.2% and Smallcap index trading flat.The retail sentiment on Stocktwits for the Nifty remained ‘bearish’ at market open.&nbsp;<figure class="image"><img style="aspect-ratio:802/94;" src="https://news.stocktwits-cdn.com/Screenshot_2025_10_01_094251_png_63cb54d831.webp" alt="Screenshot 2025-10-01 094251.png" width="802" height="94"><figcaption>Nifty sentiment and message volume on Oct 1 as of 9:40 am IST. | source: Stocktwits</figcaption></figure>Stock WatchSectorally, barring IT and PSU banks, rest of the sectors traded in the green, led by media, pharmaceuticals, real estate and autos.&nbsp;Shriram Finance rose over 2% as news reports suggest that Japan's MUFG is looking to buy a 20% stake in the company.&nbsp;Tata Motors rose 1% as its long-awaited demerger into passenger and commercial vehicle units takes effect today. <a href="https://stocktwits.com/symbol/TATAINVEST.NSE">Tata Investment</a> continues its bull run, with 4% gains in opening trade. Tata Sons, the holding company of Tata Group, holds a 0.10% stake in Tata Investment and has missed a regulatory deadline to become publicly listed as per RBI norms for NBFCs.&nbsp;<a href="https://stocktwits.com/symbol/PFIZER.NSE">Pfizer India shares</a> surged 5% after its US parent company received a three-year reprieve from tariffs on pharmaceutical imports imposed by US President Donald Trump.Lupin gained 3% following a USFDA nod for Rivaroxaban oral suspension drug, used to treat venous thromboembolism (VTE).<a href="https://stocktwits.com/symbol/RATEGAIN.NSE">RateGain shares</a> fell 3% as the company is considering acquiring Sojern and its subsidiaries through its wholly-owned subsidiary for $250 million.Newgen Software rose 2% on securing multiple deals across the UK, US, Ghana, and Dubai, with total contract wins exceeding $9 million. RITES too gained over 2% following a pact with Etihad Rail.&nbsp;Atlantaa shares surged 20% after the company entered into an agreement with IRCON International for undertaking a contract worth ₹2,485 crore.Stock CallsAnalyst&nbsp;<a href="https://stocktwits.com/Wisebull_co_in">Vinayak Gautam</a> shared three stock recommendations for Wednesday with a 1-week timeframe:<a href="https://stocktwits.com/symbol/JSWSTEEL.NSE">JSW Steel</a>: Buy at ₹1,142, with a target price of ₹1,164, and stop loss at ₹1,130<a href="https://stocktwits.com/symbol/RITES.NSE">RITES</a>: Buy at ₹246.04, with a target price of ₹254, and stop loss at ₹243<a href="https://stocktwits.com/symbol/AGIIL.NSE">Agi Infra</a>: Buy at ₹1,260, with a target price of ₹1280, and stop loss at ₹1,250<stembedurl>https://stocktwits.com/Wisebull_co_in/message/630573311</stembedurl>Markets: The Road AheadFrom a technical standpoint, SEBI-registered analysts on Stocktwits shared the trade setup.&nbsp;Analyst&nbsp;<a href="https://stocktwits.com/kyalashish">Ashish Kyal</a> said the Nifty index is managing to show reduced momentum on the downside, but has yet to see a close above the prior high. For Wednesday, a break below 24,580 can take prices to 24,520-24,480 levels. A close above<a href="https://stocktwits.com/topic/Gann">&nbsp;</a>Gann levels of 24,728 on a 15-minute timeframe is required to resume a positive trend to 24,780-24,820. A move is expected 10 minutes after the RBI policy decision.<stembedurl>https://stocktwits.com/kyalashish/message/630572014</stembedurl><a href="https://stocktwits.com/prabhatmittal1">Prabhat Mittal</a> identified Nifty support at 24,450 with resistance at 24,850. For Bank Nifty, he sees support at 54,300 and resistance at 54,900.<stembedurl>https://stocktwits.com/prabhatmittal1/message/630571237</stembedurl>Global CuesGlobally, Asian markets traded mostly higher, while crude oil prices held steady.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.

Indian Markets Open Firm Ahead Of RBI Policy; Tata Investment, Pfizer, Shriram Finance Gain Ground

 Pharma, autos, and media stocks led early gains, while Tata Motors and Atlantaa were among top movers.

Indian stocks are poised for a subdued opening on Wednesday, as the GIFT Nifty — an early indicator for the Nifty 50 index — traded flat ahead of the market open. Benchmark indexes ended lower for the eighth straight session on Tuesday, with the Nifty index closing below 24,700.All eyes will also be on the Reserve Bank of India’s (RBI) rate decision due at 10 am today. Economists expect the central bank to hold steady on rates but a dovish tone could open the path for further rate cuts going forward. Rate sensitive sectors will be in focus today.&nbsp;Most major Asian markets were mostly higher in morning trade, barring Japanese Nikkei that was down nearly 1%. Chinese markets are shut for a week for National Day holidays.Stock WatchPfizer India: The US parent company has received a three-year reprieve from tariffs on pharmaceutical imports imposed by US President Donald Trump.Aurobindo, Dr Reddy’s, other Indian pharma companies: Trump's 100% tariff on pharma takes effect todayLupin - Got USFDA nod for Rivaroxaban oral suspension drug, used to treat venous thromboembolism (VTE).Auto stocks - Investors will be tracking September sales data.Shriram Finance - News reports suggest that Japan's MUFG is looking to buy 20% stake in the company.&nbsp;Nestle India - Has signed a Memorandum of Understanding (MoU) to boost investments in Odisha &amp; existing plants.Shree Cement - The company commissioned 3.65 MTPA clinkerisation unit in Rajasthan.Indian Overseas Bank - Got ₹31.8 lakh penalty notice from RBI for non-compliance of its Priority Sector Lending (PSL) targets and classification norms.OIL India &amp; GAIL - signed a pact to boost collaboration across the natural gas value chainRateGain - The company is considering acquiring Sojern and its subsidiaries through its wholly-owned subsidiary for $250 million.Newgen Software - Company has signed multiple deals across the UK, US, Ghana, and Dubai, with total contract wins exceeding $9 million.RITES - The company has signed a pact with Etihad Rail and its subsidiary to boost collaboration in the mobility sector across the UAE.&nbsp;Atlantaa - The company has entered into an agreement with IRCON International for undertaking a contract worth ₹2,485 crore.Swan Defence has signed a Memorandum of Understanding (MoU) with Samsung Heavy Industries to jointly explore commercial shipbuilding and heavy engineering projects across domestic and international markets.Mainboard Listing Today&nbsp;Epack Prefab Technologies, BMW Ventures, and Jain Resource RecyclingFor updates and corrections, email newsroom[at]stocktwits[dot]com.

The digital broadcast on the facade of the Bombay Stock Exchange (BSE) displays the benchmark share index SENSEX crossing 32,000 points, on July 13, 2017 in Mumbai, India. (Photo by Kunal Patil/Hindustan Times via Getty Images)

Sensex, Nifty Poised For Quiet Start; Pfizer, Lupin, Tata Motors, RateGain, Newgen, RITES On Stock Watchlist

 After eight days of losses, markets may see a cautious start as the RBI policy decision takes center stage. Stock-specific action is expected in pharma, auto, and PSU banking counters.

DPIIT partners with Pfizer to boost lab-to-market pathway for healthcare innovation

New Delhi, Sep 4 : The Department for Promotion of Industry and Internal Trade (DPIIT) has signed a Memorandum of Understanding (MoU) with US-based pharma giant Pfizer to strengthen Indias healthcare and accelerate the lab-to-market journey of healthcare innovations, the Ministry of Commerce and Industry said on Thursday. The collaboration will extend both financial and non-financial support to startups. Under the partnership, the Pfizer INDovation programme will empower DPIIT-recognised startups with grants of up to Rs 60 lakhs each, along with a tailored 18-month incubation programme delivered by Social Alpha. The programme will provide dedicated acceleration tracks covering clinical validation, regulatory approvals, and go-to-market strategies. Startups will also gain access to expert mentorship, infrastructure, and global networks, in addition to exposure at Pfizers Research and Development facilities in Chennai, enabling them to strengthen innovations with advanced industry insights, the Ministry said.

Indian equity markets closed higher on Wednesday, helped by buying in pharma and metal stocks. Most sectors ended in the green as investors cheered the easing retail inflation data from July.Tracking broader Asian cues, the markets are likely to open flat-to-negative on Thursday, ahead of the F&amp;O expiry.Investors will also keep an eye out for commentary from the scheduled meeting between US President Donald Trump and Russian President Vladimir Putin on August 15.The Gift Nifty, an early indicator for the Nifty 50 index, edged 0.17% lower to 24,693.5 at 8:30 am IST. The markets will be closed on Friday on account of Indian Independence Day.Here are the stocks to watch out for heading into today’s session.Stocks To WatchInfosys: To acquire a 75% stake in Versent Group, an Australian digital transformation solutions provider and subsidiary of Telstra Group, for A$233.25 million. Telstra will retain the remaining 25%.ICICI Bank: Reduced minimum account balance requirements to ₹15,000 for metro and urban areas, ₹7,500 for semi-urban areas, and ₹2,500 for rural areas, down from ₹50,000, ₹25,000, and ₹10,000, respectively.Jain Irrigation Systems: Bagged a ₹135 crore order from MSEDCL under the PM-KUSUM B Scheme to design, supply, install, and commission 5,438 off-grid DC solar water pumps across Maharashtra.Zydus Lifesciences: Co’s Ahmedabad plant cleared a USFDA Pre-Approval Inspection for three products with no observations, while its Baddi plant received four observations (none related to data integrity) following a surveillance inspection.RVNL: Gets a ₹91 crore order from Southern Railway for video surveillance at 484 stations.Wipro: Completes its generative AI agent-building initiative with Google Cloud.Shilpa Medicare: Bonus share issue at 1:1. First in 12 years.Earnings ImpactBharat Petroleum Corporation: Q1 profit surged 140.7% to ₹6,839 crore, while revenue slipped 0.5% to ₹1,12,551.5 crore.Jubilant Foodworks: Reported a 60% jump in Q1 profit to ₹97.2 crore, while revenue rose 17% to ₹2,260.9 crore.Vishal Mega Mart: Reported a 37.2% spike in Q1 profit to ₹206.1 crore, while revenue came in 21% higher at ₹3,140.3 crore.Muthoot Finance: Q1 profit surged 73.2% to ₹2,016.2 crore, as NII jumped 42.8% to ₹3,933.1 crore.IRCTC: Reported 7.5% increase in Q1 profit to ₹330.7 crore, with revenue increasing 3.8% to ₹1,159.7 crore.Pfizer: Q1 profit rose 27.2% YoY to ₹191.8 crore, while revenue climbed 7.1% to ₹603 crore.Engineers India: Q1 profit dropped 28.6% to ₹65.4 crore, though revenue surged 39.5% to ₹870.4 crore.Aditya Birla Fashion and Retail: Q1 loss narrowed to ₹233.7 crore, with revenue growing 9.4% to ₹1,831.5 crore; Brand TMRW received ₹437 crore investment from ServiceNow Ventures.United Spirits: Profit declined 14% to ₹417 crore, while revenue grew 9.4% to ₹3,021 crore.MTNL: Q1 loss widened to ₹943.2 crore, as revenue plunged 64.2% to ₹65.7 crore.Man Infraconstruction: Q1 profit dropped 31% to ₹58.3 crore, with revenue falling 46.5% to ₹182.9 crore.Deepak Nitrite: Posted a 44.6% decline in Q1 profit to ₹112.2 crore, while revenue fell 12.8% to ₹1,889.9 crore.Texmaco Rail and Engineering: Q1 profit halved to ₹30 crore, with revenue down 16.3% to ₹910.6 crore.Brigade Enterprises: Profit soared 79% to ₹150 crore, while revenue jumped 18.9% to ₹1,281.1 crore.Shalby: Q1 profit dropped 43% to ₹8.9 crore, while revenue rose 6.3% to ₹296.4 crore.Somany Ceramics: Profit came in at ₹10.4 crore, down 15.6%, while revenue climbed 4.5% to ₹604.4 crore.Indostar Capital Finance: Q1 profit spiked 50-fold to ₹535.5 crore on a ₹1,176 crore exceptional gain, while NII rose 24.7% to ₹129.1 crore.HG Infra Engineering: Posted a 39.2% decline in Q1 profit to ₹98.8 crore, while revenue fell 3% to ₹1,482.2 crore.Endurance Technologies: Q1 profit grew 11% to ₹226.4 crore, as revenue rose 17.5% to ₹3,318.9 crore.Surya Roshni’s Q1 profit fell 63.6% to ₹33.6 crore, with revenue declining 15.2% to ₹1,604.5 crore.ITI: Loss narrowed to ₹63.6 crore in Q1, while revenue dropped 4.2% to ₹498 crore.Results Today&nbsp;&nbsp;Indian Oil Corporation, Amara Raja Energy &amp; Mobility, Ashok Leyland, AstraZeneca Pharma India, Glenmark Pharmaceuticals, Vodafone Idea, Patanjali Foods, Swan Energy, Valor Estate, Easy Trip Planners, GE Power India, Hindustan Copper, Inox Green Energy Services, Inox Wind, IRB Infrastructure Developers, and Zaggle Prepaid Ocean Services, among others.&nbsp;Mainboard ListingJSW CementActive IPOsRegaal Resources.For updates and corrections, email newsroom[at]stocktwits[dot]com.&nbsp;

Trading Radar For August 14: ICICI Bank, Infosys, Muthoot, IRCTC, RVNL, Shilpa Medicare, And Zydus Are On Stocks Watchlist

IOC, Vodafone Idea, Glenmark Pharma, and AstraZeneca Pharma, among others, are expected to post their quarterly earnings today. JSW Cement to list at 10 am.

Indian equity markets opened on a cautious note, a day after recording a sharp recovery that snapped a six-week losing streak. The Nifty holds above 24,500 even as trade remains range-bound. Investors will be eyeing the crucial CPI inflation print due later in the day.At 09:40 a.m. IST, the&nbsp;<a href="https://stocktwits.com/symbol/NIFTY50.NSE">Nifty 50</a> traded 43 points higher at 24,628, while the Sensex gained 164 points at 80,768. Broader markets underperformed, with the Nifty Midcap falling 0.1% and the Smallcap index trading flat.&nbsp;The retail sentiment on Stocktwits for Nifty remained ‘bullish’ amid ‘high’ message volumes at market open.&nbsp;<figure class="image"><img style="aspect-ratio:814/112;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_12_095544_png_c87c34a53a.webp" alt="Screenshot 2025-08-12 095544.png" width="814" height="112"><figcaption>Nifty sentiment and message volume on Aug 12 as of 9:45 am IST. | source: Stocktwits</figcaption></figure>Stock WatchSectorally, barring private banks and real estate, the rest of the indices traded in the green, with media, technology, and energy leading the pack.<a href="https://stocktwits.com/symbol/HINDALCO.NSE">Hindalco</a> opened 2% lower on subdued June quarter (Q1 FY26) earnings expectations. Astral fell 6%, Praj Industries fell 7% on disappointing Q1. On the other hand, <a href="https://stocktwits.com/symbol/TI.NSE">Tilaknagar</a> surged 6%, Awfis rallied 9%, following strong earnings.&nbsp;Pfizer India gained 2% on launching the pneumococcal conjugate vaccine (PCV20) in India.Indian Hotels rose over 1% after the board approved the acquisition of controlling stakes in ANK Hotels and Pride Hospitality for up to ₹204 crore.And <a href="https://stocktwits.com/symbol/MEDIASSIST.NSE">Medi Assist</a> surged over 5% following a large block deal. Reports suggest that the promoter was looking to offload 4% stake.Watch out for Hindustan Aeronautics, Apollo Hospitals, Honasa Consumer, Alkem Laboratories, Cochin Shipyard, Bharat Dynamics, ONGC, Jindal Steel &amp; Power, FSN E-Commerce, Zydus Lifesciences, and Suzlon, among others, as they report quarterly earnings today.&nbsp;Markets: The Road AheadFrom a technical standpoint, SEBI-registered analysts on Stocktwits shared the trade setup.&nbsp;<a href="https://stocktwits.com/Japfinserve">Varunkumar Patel</a> noted that Foreign Institutional Investors (FIIs) sold nearly ₹1,200 crore worth of equities in the cash market. In the F&amp;O segment, they trimmed some index short positions, but overall positioning still leans cautious. He expects Nifty to trade in a broad range of 23,850–24,900 until there are fresh triggers. Short-term moves are likely to remain choppy. Overall, the Put-Call ratio (PCR) is now standing at 1.0, which indicates markets are not out of oversold territory.&nbsp;&nbsp;All eyes are on the US inflation data and India’s CPI data today. He believes that both could set the tone for the next move in global and domestic markets. Macro events and news flow till August 15 may keep volatility high. He advised traders to avoid over-leveraging and chase only high-conviction setups.<stembedurl>https://stocktwits.com/Japfinserve/message/624709326</stembedurl><a href="https://stocktwits.com/prabhatmittal1">Prabhat Mittal</a> identified Nifty support at 24,380 with resistance at 24,720. For the Bank Nifty, he sees support at 55,100 and resistance at 55,900.<stembedurl>https://stocktwits.com/prabhatmittal1/message/624707302</stembedurl>Global CuesGlobally, Asian markets traded mixed even as the US-China trade truce was extended by 90 days, while crude oil prices edged higher as investors awaited the outcome of U.S.-Russia talks aimed at resolving the Ukraine conflict, scheduled for August 15.For updates and corrections, email newsroom[at]stocktwits[dot]com.

An outside view of Bombay Stock Exchange on May 15, 2015 in Mumbai, India. (Photo by Aniruddha Chowdhury/Mint via Getty Images)

Indian Markets Trade Rangebound Ahead of Crucial CPI Data; Broader Markets Lag

Key inflation data and earnings from major companies such as HAL, ONGC, and Suzlon are expected to set the near-term tone.

Indian equity markets closed in the green on Monday, boosted by gains by state-run banks, and real estate stocks in particular. Overall, every index, barring consumer durables, ended on a positive note.AMFI data shows that equity mutual fund inflows soared to an all-time high of ₹42,672 crore in July 2025, up from ₹23,568 crore in June, led by record NFO collections of ₹30,416 crore.The markets are likely to open slightly higher on Tuesday, tracking broader Asian markets, as investors await domestic inflation data for July. Key PSUs, including ONGC, NHPC, and NMDC, are expected to post their quarterly earnings later in the day.The Gift Nifty, an early indicator for the Nifty 50 index, edged up 0.30% to 24,624.5 at 8:30 am IST.Here are the stocks to watch out for heading into today’s session.Stocks To WatchPfizer: Introduced its next-generation 20-valent pneumococcal conjugate vaccine (PCV20) in India, aimed at adult immunisation against 20 serotypes causing most invasive and non-invasive pneumococcal diseases.Indian Hotels: To acquire controlling stakes in ANK Hotels and Pride Hospitality for up to ₹204 crore to expand its portfolio.Medi Assist: Promoter Bessemer India is likely to sell up to a 4% stake via a ₹560-crore block deal.Adani Enterprises: Subsidiary Horizon Aero Solutions will acquire a 100% stake in Indamer Technics.Inox Green: Signs agreement for O&amp;M of 182 MW of wind projects across multiple sites in Western India.Astral: Board approves plan to acquire an 80% equity stake in Nexelon Chem and a further investment of up to ₹120 crore.Ceigall India: Identified as the lowest bidder for a ₹225 crore project for the development of a Bulk Drug Park.Tilaknagar Industries: To expand the production capacity of Prag Distillery with a capital expenditure of ₹25 crore.Earnings ImpactBata India: Q1 consolidated net profit slumped 70.1% to ₹52 crore, with revenue slipping 0.3% to ₹941.8 crore.Ashoka Buildcon: Posted a 44.6% increase in consolidated net profit at ₹217.3 crore, while revenue fell 23.5% to ₹1,887 crore.Som Distilleries: Q1 consolidated net profit increased 3.7% to ₹42 crore, with revenue up 3% to ₹528.4 crore.Man Industries: Consolidated net profit surged 45.2% to ₹27.6 crore, while revenue dipped 0.9% to ₹742.1 crore.Muthoot Microfin: Consolidated net profit tanked 94.5% to ₹6.2 crore, as NII dropped 16% to ₹309 crore in Q1.Results Today&nbsp;&nbsp;Oil and Natural Gas Corporation, Hindalco Industries, Apollo Hospitals Enterprise, Bharat Dynamics, National Securities Depository (NSDL), Zydus Lifesciences, FSN E-Commerce Ventures Nykaa, Honasa Consumer, Alkem Laboratories, Jindal Steel &amp; Power, Abbott India, Dr Agarwals Health Care, Dr Agarwals Eye Hospital, EMS, Hindustan Aeronautics, Jyothy Labs, Karnataka Bank, Natco Pharma, Nazara Technologies, NHPC, NMDC, Oil India, Rashtriya Chemicals and Fertilizers, Rail Vikas Nigam, Senco Gold, Suzlon Energy, and VA Tech Wabag, among others.&nbsp;Active IPOsBluestone Jewellery &amp; LifestyleMainboard ListingHighway InfrastructureFor updates and corrections, email newsroom[at]stocktwits[dot]com.

Trading Radar For August 12: Hindalco, Adani Enterprises, Bata, Pfizer, Ashoka Buildcon, And Inox Green Are On Stocks Watchlist

ONGC, NHPC, NMDC, Zydus, and Bharat Dynamics, among others, are expected to post their quarterly earnings today. Highway Infrastructure is set to list on the mainboard today.

Pfizer board approves marketing, supply pact with Mylan for two brands

Pfizer Ltd's board has approved a five-year marketing and supply agreement with Mylan Pharmaceuticals for the brands Ativan and Pacitane, targeting the treatment of anxiety disorders and Parkinsonism. The partnership leverages Mylan's expertise in the central nervous system therapy area to enhance product distribution and engagement with neurologists and psychiatrists in India.

Pfizer Ltd. engages in the business of manufacturing, marketing, trading, import and export of pharmaceutical products. Its product offerings include treatment for depression, erectile dysfunction, high cholesterol, human immunodeficiency virus infection, hypertension, bacterial infections and systemic fungal infections, and other chronic therapeutic which includes pain, respiratory, vitamins or minerals, hospital anti-infectives, neurosciences, and cardiovascular. The firm's products include Prevenar 13, Ativan, Zosyn, Minipress XL, Meronem, Enbrel, Dolonex, Magnex, Trulimax, Neksium, Becosules, Gelusil, Mucaine, Folvite, Autrin, Citralka, and Corex Range. It operates through the India and Outside of India geographical segments. The company was founded on November 21, 1950 and is headquartered in Mumbai, India.

Current Price	5,220.50
Prev Close	5,147.00
Open	5,192.00
Dividend Yield	0.87%
50-Day Moving Average	5,199.12
Beta	-0.01
Avg. Volume	15,621.27
PE Ratio	29.55

52-Week High	5,886.25
52-Week Low	3,618.77
Market Capitalization	238.92B
EPS (Annual)	167.79
Price to Book	5.67
Revenue Per Employee	12.9M
Enterprise Value/EBITDA	N/A

PFIZER.NSE
Pfizer Ltd.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest PFIZER.NSE News

PFIZER.NSE Pfizer Ltd.